共查询到20条相似文献,搜索用时 109 毫秒
1.
目的了解灯盏花素对椎-基底动脉供血不足的治疗效果。方法将80例椎-基底动脉供血不足患者随机分为两组,观察组给予灯盏花素治疗,时照组给予复方丹参治疗。疗程7天,比较两组患者的临床疗效。结果观察组总有效率92.5%,对照组总有效率77.5%,两组比较差异有显著统计学意义(P〈0.05)。结论灯盏花素治疗椎-基底动脉供血不足效果优于复方丹参。 相似文献
2.
方法:将100例椎-基底动脉供血不足患者随机分为两组。治疗组50例,给予灯盏花素和培他啶、维脑路通;对照组50例,仅给予培他啶和维脑路通。疗程7天,观察并比较两组患者的临床疗效。结果:治疗组的总有效率显著高于对照组(P〈0.05),证明灯盏花素治疗椎-基底动脉供血不足有较好疗效。 相似文献
3.
4.
灯盏花素治疗椎基底动脉供血不足性眩晕85例 总被引:1,自引:0,他引:1
目的 观察灯盏花素对椎基底动脉供血不足性眩晕的治疗效果。方法 将85例椎基底动脉供血不足患者随机分为观察组46例(给予灯盏花索治疗)与对照组39例(用复方丹参注射液治疗),观察二组治疗前后临床症状的变化.对比观察其疗效。结果 治疗后惠者眩晕得到不同程度的缓解.观察组临床疗效(91.3%)与对照组(69.23%)比较差异有统计学意义(P〈0.05)。结论 灯盏花素对椎基底动脉供血不足性眩晕有良好的改善作用.其疗效明显优于复方丹参注射液的治疗效果。 相似文献
5.
目的观察灯盏花素对椎-基底动脉供血不足性眩晕的治疗效果。方法将96例椎-基底动脉供血不足性眩晕患者按用药不同分为观察组(给予灯盏花素治疗)50例与对照组(给予复方丹参治疗)46例,通过3~7d治疗,对比观察两组治疗前后眩晕临床症状的变化。结果治疗后两组患者眩晕症状得到缓解程度不同,观察组临床总有效率90.0%(45/50),对照组临床总有效率71.7%(33/46),差异有统计学意义(P〈0.05)。结论灯盏花素对椎-基底动脉供血不足性眩晕患者有明显疗效。 相似文献
6.
目的 观察灯盏花素注射液治疗椎-基底动脉供血不足的临床疗效.方法 选择椎-基底动脉供血不足63例随机分成两组,灯盏花素注射液治疗组42例,西医对照组21例,治疗28d为1个疗程.观察临床疗效和椎-基底动脉的平均血流速度(Vm).结果 灯盏花素注射液治疗组优于对照组,两组比较差异有统计学意义(P<0.05或0.01).结论 灯盏花素注射液是治疗椎-基底动脉供血不足安全有效药物. 相似文献
7.
目的观察灯盏花素联合山莨菪碱治疗椎-基底动脉供血不足所引起的发作性眩晕等症状的缓解情况。方法治疗组51例给予灯盏花素联合山莨菪碱,对照组38例给予灯盏花素。结果治疗组在用药3d后总有效率为76.5%,对照组总有效率为55.3%,有显著性差异(P〈0.05)。结论灯盏花素联合山莨菪碱治疗椎一基底动脉供血不足时,在起效时间上显著优于单用灯盏花素,且副作用少,该方法值得推广。 相似文献
8.
目的观察灯盏花素联合山莨菪碱治疗椎-基底动脉供血不足所引起的发作性眩晕等症状的缓解情况。方法治疗组51例给予灯盏花素联合山莨菪碱,对照组38例给予灯盏花素。结果治疗组在用药3d后总有效率为76.5%,对照组总有效率为55.3%,有显著性差异(P〈0.05)。结论灯盏花素联合山莨菪碱治疗椎一基底动脉供血不足时,在起效时间上显著优于单用灯盏花素,且副作用少,该方法值得推广。 相似文献
9.
灯盏细辛注射液治疗椎-基底动脉供血不足 总被引:1,自引:0,他引:1
目的 观察灯盏细辛注射液治疗椎-基底动脉供血不足的临床疗效及可信度.方法 将85例椎-基底动脉供血不足患者随机分为2组,观察组42例给予灯盏细辛注射液静脉滴注治疗,对照组给盐酸丁咯地尔注射液静脉滴注治疗,观察治疗后两组患者症状、血脂、血流变学改变及副作用情况.结果 两组的症状痊愈率分别为90%,82.5%,两组对比差异有显著性(P<0.05);灯盏细辛注射液能有效地降低血脂、改善血流变学(均P<0.05);灯盏细辛注射液复发率明显低于对照组(P<0.05).结论 灯盏细辛治疗椎基底动脉效果明显.较盐酸丁咯地尔复发率更低,且安全,副作用小. 相似文献
10.
杨俊彦 《中华医学实践杂志》2006,5(9):976-977
目的观察疏血通注射液治疗椎-基底动脉供血不足的临床疗效,并探讨其作用机制。方法将62例椎-基底动脉供血不足病人随机分为治疗组和对照组,治疗组用疏血通注射液治疗,对照组用复方丹参注射液治疗,观察临床疗效并检测血脂、血液流变学水平及TCD。结果治疗组的治愈率、总有效率分别为53.1%、90.6%,对照组为30.0%、76.7%。治疗组在降低甘油三酯、胆固醇及升高高密度脂蛋白等方面,治疗前后比较有统计学意义(P〈0.05或P〈0.01)。结论疏血通注射液治疗椎-基底动脉供血不足疗效好,毒副反应少。 相似文献
11.
Insufficient blood supply to vertebrobasilarartery is one of the ischemic cerebrovascular diseasesencountered commonly and frequently in old people.Its clinical symptoms are capricious,and severeischemia may jeopardize the life of the patient.Thekey point for saving the patient's life and raising thequality of life is to relieve the symptoms and improveblood supply to the brain.From May 1995 to May 相似文献
12.
目的 :观察灯盏细辛注射液对椎 -基底动脉供血不足性眩晕患者的治疗效果。方法 :将患者随机分为治疗组 (灯盏细辛组 )和对照组 (丹参组 )分别在治疗前后检查血液流变学指标和头颅多普勒结果 ,以评价两组疗效。结果 :治疗组治疗后血液流变学指标与治疗前比较差异有显著性 (P <0 .0 5 ) ,与对照组治疗后比较差异亦有显著性 (P <0 .0 5 ) ;治疗组治疗后TCD结果与治疗前比较差异有显著性 (P <0 .0 5 ) ,与对照组治疗后比较差异亦有显著性 (P <0 .0 5 )。结论 :应用灯盏细辛注射液治疗椎 -基底动脉供血不足性眩晕患者能够更有效降低血粘度 ,增加脑血流 ,改善脑血液循环 ,增加脑组织灌注 相似文献
13.
灯盏花注射液治疗急性脑梗死128例 总被引:3,自引:1,他引:2
目的 观察云南灯盏花注射液治疗脑梗死的临床疗效。方法 选择急性脑梗死2 33例 ,随机分为两组 ,治疗组用灯盏花注射液 30ml加入 5 %葡萄糖 2 5 0ml静脉滴注 ,对照组用复方丹参注射液 2 0ml,黄芪注射液 2 0ml加入 5 %葡萄糖 2 5 0ml静脉滴注 ,均为每日 1次 ,疗程为 15d。结果 治疗组总有效率 93.8% ,对照组总有效率 77.1% ,有显著差异 (P <0 .0 1)。结论 灯盏花注射液治疗脑梗死有较好疗效 相似文献
14.
椎基底动脉供血不足109例分析 总被引:16,自引:0,他引:16
0引言椎基底动脉供血不足在临床上日益多见,但由于临床表现的复杂性、多变性特征,有时难以及时诊治[1-3]. 1临床资料2002-03/2002-09门诊和住院确诊椎基底动脉供血不足患者109(男40,女69)例,年龄24~85(平均51.7)岁. 相似文献
15.
目的 了解灯盏花素治疗椎基底动脉供血不足(VBI)临床疗效及治疗前后经颅多普勒(TCD)变化情况.方法 选取椎基底动脉供血不足患者160例,随机分成2组,灯盏花素组80例,低分子右旋糖苷组80例,比较治疗前后临床疗效及TCD变化情况.结果 灯盏花素可明显改善患者眩晕、呕吐等临床症状,总有效率达97.50%,明显高于对照组83.75%(P<0.05),且TCD结果显示治疗后治疗组椎基底动脉系统血流速度增快优于对照组(P<0.01).结论 灯盏花素可有效治疗椎基底动脉供血不足. 相似文献
16.
灯盏花素注射液治疗急性脑出血62例 总被引:2,自引:1,他引:1
目的 观察灯盏花素注射液治疗急性脑出血的临床疗效。方法 12 3例急性脑出血患者随机分观察组 6 2例 ,对照组 6 1例 ,两组常规治疗相同 ,观察组早期加用灯盏花素注射液 ,并分别对两组治疗前后进行神经功能缺损评分。结果 观察组总有效率 (91.9% )和显效率 (72 .6 % )明显高于对照组 (82 .0 %和 4 9.2 % ,P <0 .0 1)。结论 灯盏花素注射液治疗急性脑出血疗效好 ,副作用少 相似文献
17.
目的观察丹红注射液治疗椎-基底动脉供血不足(VBI)的临床疗效及安全性。方法将92例诊断为VBI的患者随机分为治疗组和对照组各46例,治疗组予丹红注射液治疗,对照组予复方丹参注射液治疗。观察两组临床效果,治疗组于治疗前后进行血流动力学指标的测定。结果治疗组的总有效率为97.8%,显著高于对照组的82.6%(p〈0.05)。治疗组在治疗后TCD各参数均有明显改善(p〈0.01)。结论丹红注射液治疗VBI疗效肯定,能明显改善患者的血流动力学指标。 相似文献
18.
通心络胶囊治疗椎基底动脉供血不足50例临床疗效评价 总被引:1,自引:0,他引:1
目的:观察通心络胶囊治疗椎基底动脉供血不足的临床疗效.方法:将118例椎基底动脉供血不足患者随机分为治疗组和对照组,治疗组口服通心络胶囊,对照组口服复方丹参片,均连续治疗8周,治疗前和治疗8周后予评分,并做经颅多普勒超声和血液流变学检查.结果:治疗组降低血黏度、增加椎动脉和基底动脉平均血流速度均较对照组明显(P<0.05);治疗组改善临床症状的总有效率为96.0%,对照组为85.3%,前者明显高于后者(P<0.05).结论:通心络胶囊对椎基底动脉供血不足具有良好的治疗作用. 相似文献
19.
20.
Treatment of patients older than 60 years with symptomatic vertebrobasilar artery stenosis 总被引:1,自引:1,他引:0
Background Vertebrobasilar artery stenosis is an important cause of ischemic posterior circulation strokes. This study aimed at evaluating the safety and efficacy of treatment including conservative therapy alone and conservative plus endovascular therapy for elderly patients with symptomatic vertebrobasilar artery stenosis.
Methods Patients older than 60 years with symptomatic vertebrobasilar artery stenosis ( ≥50%) confirmed by cerebral angiography were enrolled. All of them were treated with medical therapy and some with additional stent-assisted angioplasty (the stenting subgroup). Their clinical, imaging, intervention and follow-up data were analyzed.Results One hundred and seventeen consecutive elderly patients (100 men, mean age (68.1 ±5.1) years) were enrolled and followed up for a mean time of 28.4 months; 81.7% of them were symptomatically resolved or improved; a stroke rate of 5.1% and a stroke-related death rate of 1.7% were found among them during the hospitalization and follow-up. In the stenting subgroup, 78 balloon expandable stents were employed in the 70 patients with a technical success rate of 98.7% and the mean degree of stenosis was significantly reduced from (81.7±14.3)% before stenting to (8.3±4.2)% after stenting (P 〈0.001). Four (5.7%) periprocedural strokes occurred, of whom two led to death within 30 days after the procedure. During the follow-up (mean 27.7 months), sixty of the surviving 68 patients in the stenting subgroup were symptomatically resolved or improved. Only one (1.5%) posterior circulation stroke occurred, while duplex ultrasound scan of 34 patients demonstrated 10 (29.4%) in-stent restenosis.
Conclusions Appropriate utilization of conservative therapy alone and conservative plus endovascular therapy may improve short-term clinical outcomes for elderly patients with symptomatic vertebrobasilar artery stenosis. Furthermore, stent-assisted angioplasty is technically feasible and relatively safe in elderly patients. 相似文献
Methods Patients older than 60 years with symptomatic vertebrobasilar artery stenosis ( ≥50%) confirmed by cerebral angiography were enrolled. All of them were treated with medical therapy and some with additional stent-assisted angioplasty (the stenting subgroup). Their clinical, imaging, intervention and follow-up data were analyzed.Results One hundred and seventeen consecutive elderly patients (100 men, mean age (68.1 ±5.1) years) were enrolled and followed up for a mean time of 28.4 months; 81.7% of them were symptomatically resolved or improved; a stroke rate of 5.1% and a stroke-related death rate of 1.7% were found among them during the hospitalization and follow-up. In the stenting subgroup, 78 balloon expandable stents were employed in the 70 patients with a technical success rate of 98.7% and the mean degree of stenosis was significantly reduced from (81.7±14.3)% before stenting to (8.3±4.2)% after stenting (P 〈0.001). Four (5.7%) periprocedural strokes occurred, of whom two led to death within 30 days after the procedure. During the follow-up (mean 27.7 months), sixty of the surviving 68 patients in the stenting subgroup were symptomatically resolved or improved. Only one (1.5%) posterior circulation stroke occurred, while duplex ultrasound scan of 34 patients demonstrated 10 (29.4%) in-stent restenosis.
Conclusions Appropriate utilization of conservative therapy alone and conservative plus endovascular therapy may improve short-term clinical outcomes for elderly patients with symptomatic vertebrobasilar artery stenosis. Furthermore, stent-assisted angioplasty is technically feasible and relatively safe in elderly patients. 相似文献